Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Nat Biotechnol. 2019 Jul;37(7):708-711. doi: 10.1038/s41587-019-0175-2.

Pre-market development times for biologic versus small-molecule drugs.

Author information

1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. reed.beall@ucalgary.ca.
2
Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada. reed.beall@ucalgary.ca.
3
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
PMID:
31213674
DOI:
10.1038/s41587-019-0175-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center